Bacterial profile and antibiotic resistance in pediatric appendicitis: retrospective analysis and associated laboratory and clinical findings
DOI:
https://doi.org/10.3855/jidc.21789Keywords:
pediatric patient, appendicitis, Escherichia coli, antibiotic resistance, bacterial profilingAbstract
Introduction: Identifying the bacterial profile in acute appendicitis, which is a common paediatric surgical emergency, can guide antibiotic therapy and improve outcomes. Therefore, the objective of this study is to evaluate the bacterial profile in paediatric appendicitis and its association with clinical and laboratory findings.
Methodology: A retrospective study was conducted on paediatric patients (≤ 14 years) who underwent appendectomy at King Fahad Hospital, Al-Baha, from 1 January 2019 to 1 October 2023. Data collected included demographics, clinical presentation, laboratory results, intraoperative findings, bacterial cultures, antibiotic regimens, and outcomes. Kruskal–Wallis and Mann–Whitney tests were performed. The normality of the data was evaluated using the Kolmogorov–Smirnov and Shapiro–Wilk tests. A p < 0.05 was considered statistically significant.
Results: In 170 patients (mean age of 10.02 years; 62.9% male), the prevalent symptoms were right lower quadrant pain (94.7%) and nausea or vomiting (80.6%). Preoperative antibiotics were administered in 91.8% of the patients. Peritoneal fluid cultures were positive in 28.8%, and Escherichia coli was the dominant isolate (60.2%). Antibiotic resistance was significantly associated with elevated white blood cell count (p = 0.003), high polymorphonuclear granulocytes (p = 0.032), abscess formation (p = 0.008), and perforation (p = 0.016). The mean hospital stay was 4.5 days, and postoperative complications occurred in 1.8% of patients.
Conclusions: E. coli is the predominant pathogen in paediatric appendicitis, with significant resistance in complicated cases. Tailored antibiotic therapy is crucial to reducing complications, but more studies are needed to refine empirical antibiotic selection.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 khalid Alzahrani, Tayyaba Batool, Ahmed Hussein, Abdullahi Alghamd, Meshal Alzhrani, Sarah Alghamdi, Norah Alharthi, Mohammad Barnawi

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

